Cargando…

MicroRNA-30a-5p(me): a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma in tissue and urine samples

BACKGROUND: The rising incidence of renal cell carcinomas (RCC) constitutes a significant challenge owing to risk of overtreatment. Because aberrant microRNA (miR) promoter methylation contributes to cancer development, we investigated whether altered miR-30a-5p expression associates with DNA promot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Outeiro-Pinho, Gonçalo, Barros-Silva, Daniela, Aznar, Elena, Sousa, Ana-Isabel, Vieira-Coimbra, Márcia, Oliveira, Jorge, Gonçalves, Céline S., Costa, Bruno M., Junker, Kerstin, Henrique, Rui, Jerónimo, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323611/ https://www.ncbi.nlm.nih.gov/pubmed/32487203 http://dx.doi.org/10.1186/s13046-020-01600-3

Ejemplares similares

Correction: MicroRNA-30a-5p(me): a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma in tissue and urine samples
por: Outeiro-Pinho, Gonçalo, et al.
Publicado: (2022)

Renal Cell Tumors: Uncovering the Biomarker Potential of ncRNAs
por: Outeiro-Pinho, Gonçalo, et al.
Publicado: (2020)

Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine
por: Lima, Ana Rita, et al.
Publicado: (2019)

GC‐MS metabolomics‐based approach for the identification of a potential VOC‐biomarker panel in the urine of renal cell carcinoma patients
por: Monteiro, Márcia, et al.
Publicado: (2017)

A Multiplex Test Assessing MiR663a(me) and VIM(me) in Urine Accurately Discriminates Bladder Cancer from Inflammatory Conditions
por: Monteiro-Reis, Sara, et al.
Publicado: (2020)

Novel Insights on the Role of Epigenetics in Androgen Receptor’s Expression in Prostate Cancer
por: Camilo, Vânia, et al.
Publicado: (2023)

Prognostic Value of Plasma and Urine Glycosaminoglycan Scores in Clear Cell Renal Cell Carcinoma
por: Gatto, Francesco, et al.
Publicado: (2016)

Characterization of CD147, CA9, and CD70 as Tumor-Specific Markers on Extracellular Vesicles in Clear Cell Renal Cell Carcinoma
por: Himbert, Dirk, et al.
Publicado: (2020)

Overexpression of the Mitotic Checkpoint Genes BUB1 and BUBR1 is Associated with Genomic Complexity in Clear Cell Kidney Carcinomas
por: Pinto, Mafalda, et al.
Publicado: (2008)

Nuclear Magnetic Resonance metabolomics reveals an excretory metabolic signature of renal cell carcinoma
por: Monteiro, Márcia S., et al.
Publicado: (2016)

CircME1 promotes aerobic glycolysis and sunitinib resistance of clear cell renal cell carcinoma through cis-regulation of ME1
por: Zhang, Ming-xiao, et al.
Publicado: (2022)

Overexpression of circulating MiR-30b-5p identifies advanced breast cancer
por: Estevão-Pereira, Helena, et al.
Publicado: (2019)

Application of Proteogenomics to Urine Analysis towards the Identification of Novel Biomarkers of Prostate Cancer: An Exploratory Study
por: Lima, Tânia, et al.
Publicado: (2022)

Discovery of Volatile Biomarkers for Bladder Cancer Detection and Staging through Urine Metabolomics
por: Pinto, Joana, et al.
Publicado: (2021)

Identification of clear cell renal cell carcinoma and oncocytoma using a three-gene promoter methylation panel
por: Pires-Luís, Ana Sílvia, et al.
Publicado: (2017)

Volatilomics Reveals Potential Biomarkers for Identification of Renal Cell Carcinoma: An In Vitro Approach
por: Amaro, Filipa, et al.
Publicado: (2020)

Excavation of diagnostic biomarkers and construction of prognostic model for clear cell renal cell carcinoma based on urine proteomics
por: Yang, Yiren, et al.
Publicado: (2023)

RAD51B(me) Levels as a Potential Predictive Biomarker for PD-1 Blockade Response in Non-Small Cell Lung Cancer
por: Guerreiro, Inês Maria, et al.
Publicado: (2020)

Human Interleukin-1β Profile and Self-Reported Pain Monitoring Using Clear Aligners with or without Acceleration Techniques: A Case Report and Investigational Study
por: Pascoal, Selma, et al.
Publicado: (2022)

Scissor Bite in Growing Patients: Case Report Treated with Clear Aligners
por: Pinho, Teresa, et al.
Publicado: (2023)

Metabolomic study of human tissue and urine in clear cell renal carcinoma by LC-HRMS and PLS-DA
por: Nizioł, Joanna, et al.
Publicado: (2018)

Identification of high-risk patients with clear cell renal cell carcinoma based on interphase-FISH
por: Sanjmyatav, J, et al.
Publicado: (2014)

SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3
por: Vieira, Filipa Quintela, et al.
Publicado: (2015)

Discrimination between the human prostate normal and cancer cell exometabolome by GC-MS
por: Lima, Ana Rita, et al.
Publicado: (2018)

GC-MS Metabolomics Reveals Distinct Profiles of Low- and High-Grade Bladder Cancer Cultured Cells
por: Rodrigues, Daniela, et al.
Publicado: (2019)

Dermoscopic features of clear cell acanthoma
por: Cunha, Daniela Gomes, et al.
Publicado: (2018)

A Rapid and Simple Procedure for the Establishment of Human Normal and Cancer Renal Primary Cell Cultures from Surgical Specimens
por: Valente, Maria João, et al.
Publicado: (2011)

GC-MS-Based Endometabolome Analysis Differentiates Prostate Cancer from Normal Prostate Cells
por: Lima, Ana Rita, et al.
Publicado: (2018)

Production of neutrons with protons or 22, 30 and 40 MeV
por: Amos, Thomas M, et al.
Publicado: (2003)

A 30 MeV H- cyclotron for isotope production
por: Milton, B F, et al.
Publicado: (1989)

Simulation of performance of 30 MeV LIL-V buncher
por: Kulinski, S, et al.
Publicado: (1985)

Detection of let-7 miRNAs in urine supernatant as potential diagnostic approach in non-metastatic clear-cell renal cell carcinoma
por: Fedorko, Michal, et al.
Publicado: (2017)

Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients
por: Moreira-Barbosa, Catarina, et al.
Publicado: (2018)

The Complex Interplay between Metabolic Reprogramming and Epigenetic Alterations in Renal Cell Carcinoma
por: Lameirinhas, Ana, et al.
Publicado: (2019)

PSB ME 30.5.96: 2Qy=11 revisited
por: Schindl, K
Publicado: (1996)

Beep4Me: Automatic Ticket Validation to Support Fare Clearing and Service Planning
por: Tuveri, Giovanni, et al.
Publicado: (2022)

Blood- and Urine-Based Liquid Biopsy for Early-Stage Cancer Investigation: Taken Clear Renal Cell Carcinoma as a Model
por: liu, Xiaoyan, et al.
Publicado: (2023)

Clearing up Clear Cell: Clarifying the Immuno-Oncology Treatment Landscape for Metastatic Clear Cell RCC
por: Doppalapudi, Sai Krishnaraya, et al.
Publicado: (2021)

MicroRNA-30e-3p inhibits cell invasion and migration in clear cell renal cell carcinoma by targeting Snail1
por: Wang, Daya, et al.
Publicado: (2017)

Update on the treatment of metastatic clear cell and non-clear cell renal cell carcinoma
por: Xu, Kevin Y, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rupvm8h2a1a68kpaldv9d40257